These observations suggest that these data-driven cluster-specific polygenic risk scores relate to characteristic individual-level differences in the anatomic distribution of TDP-43 within the ALS-FTD clinicopathologic spectrum. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.